Dora Why do you think Leo held meetings with Pha
Post# of 72440
How about this scenario. Pharma agrees B works based on the OUTSTANDING results in the UP/UPS trial. So get me a pill that targets the Colon which they just did and we will deal.
How about say $25m for that successful UC P1 result(more than enough to run P2a) and we will then receive major milestone money or not based on the P2a results. Success in P2a= BIG money. Failure Pharma loses nothing but $25m.
Potential DOMINATE entry in to a $7-8B UC market for a mere $25m?
As for the AS deal don't be surprised if they hand it back to Leo since IPIX now has a pill to do that job.